Percentage of excess body mass index loss and cardiometabolic risk reduction in Peruvian adults undergoing sleeve gastrectomy

Obesity Medicine - Tập 39 - Trang 100488 - 2023
María Luisa Bardelli1, Marycielo Neciosup-Leon2, Carlos S. Castilla-Espinoza1,3, Luciana Torres-Pesantes4, Paola K. Rodrigo-Gallardo5, Medalit E. Huamanchumo-Suyon6, Guido Bendezu-Quispe7, Gustavo Salinas-Sedo1, Carlos J. Toro-Huamanchumo1,8
1Unidad de Investigación Multidisciplinaria, Clínica Avendaño, Lima, Peru
2Universidad Católica Santo Toribio de Mogrovejo, Chiclayo, Peru
3Asociación Científica Médico Estudiantil USAT, Chiclayo, Peru
4Universidad Peruana de Ciencias Aplicadas, Lima, Peru
5Universidad Particular de Chiclayo, Chiclayo, Peru
6Hospital Nacional Almanzor Aguinaga Asenjo, Essalud, Chiclayo, Peru
7Centro de Investigación Epidemiológica en Salud Global, Universidad Privada Norbert Wiener, Lima, Peru
8Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Peru

Tài liệu tham khảo

Ali, 2018, Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on Bangladeshi adults, PLoS One, 13, 10.1371/journal.pone.0206850 Andersson, 2014, Changes in subcutaneous fat cell volume and insulin sensitivity after weight loss, Diabetes Care, 37, 1831, 10.2337/dc13-2395 Bailey-Davis, 2022, Impact of sustained weight loss on cardiometabolic outcomes, Am. J. Cardiol., 162, 66, 10.1016/j.amjcard.2021.09.018 Deitel, 2007, Reporting weight loss 2007, Obes. Surg., 17, 565, 10.1007/s11695-007-9116-0 Dixon, 2005, Minimal reporting requirements for weight loss: current methods not ideal, Obes. Surg., 15, 1034, 10.1381/0960892054621053 Florez, 2006, C-reactive protein is elevated in obese patients with the metabolic syndrome, Diabetes Res. Clin. Pract., 71, 92, 10.1016/j.diabres.2005.05.003 García de la Torre, 2008, Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin, J. Clin. Endocrinol. Metab., 93, 4276, 10.1210/jc.2007-1370 Gesteiro, 2021, Early identification of metabolic syndrome risk: a review of reviews and proposal for defining pre-metabolic syndrome status, Nutr. Metabol. Cardiovasc. Dis., 31, 2557, 10.1016/j.numecd.2021.05.022 Gloy, 2013, Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials, BMJ, 347, f5934, 10.1136/bmj.f5934 Indumathy, 2018, Contribution of insulin resistance to decreased baroreceptor sensitivity & cardiometabolic risks in pre-obesity & obesity, Indian J. Med. Res., 148, 151, 10.4103/ijmr.IJMR_1751_16 Iwamoto, 2021, Obesity management in cardiometabolic disease: state of the art, Curr. Atherosclerosis Rep., 23, 59, 10.1007/s11883-021-00953-0 Ji, 2021, Effect of bariatric surgery on metabolic diseases and underlying mechanisms, Biomolecules, 11, 1582, 10.3390/biom11111582 Jiwani, 2019, The shift of obesity burden by socioeconomic status between 1998 and 2017 in Latin America and the Caribbean: a cross-sectional series study, Lancet Global Health, 7, e1644, 10.1016/S2214-109X(19)30421-8 Kimball, 2019, Retrospective analysis of cardiovascular disease risk parameters in participants of a preventive health and wellness program, Integr Med Encinitas Calif, 18, 78 Kiriyama, 2021, Association between changes in body weight and lipid profile in the general population: a community-based cohort study, Eur. Heart J., 7, 109 Kunešová, 2012, Fatty acid composition of adipose tissue triglycerides after weight loss and weight maintenance: the DIOGENES study, Physiol. Res., 61, 597, 10.33549/physiolres.932414 Kwok, 2014, Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis, Int. J. Cardiol., 173, 20, 10.1016/j.ijcard.2014.02.026 Laing ST, Smulevitz B, Vatcheva KP, Rahbar MH, Reininger B, McPherson DD, et al. Subclinical atherosclerosis and obesity phenotypes among Mexican Americans. J. Am. Heart Assoc.. 4(3):e001540. Lanas, 2016, Prevalence, distributions and determinants of obesity and central obesity in the southern cone of America, PLoS One, 11, 10.1371/journal.pone.0163727 Lavie, 2017, Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise, J. Am. Coll. Cardiol., 70, 2022, 10.1016/j.jacc.2017.09.002 Lupoli, 2016, Effects of bariatric surgery on markers of subclinical atherosclerosis and endothelial function: a meta-analysis of literature studies, Int. J. Obes., 40, 395, 10.1038/ijo.2015.187 Lynch, 2012, Bariatric surgery is effective and safe in patients over 55: a systematic review and meta-analysis, Obes. Surg., 22, 1507, 10.1007/s11695-012-0693-1 Maciejewski, 2016, Bariatric surgery and long-term durability of weight loss, JAMA Surg, 151, 1046, 10.1001/jamasurg.2016.2317 Magkos, 2016, Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity, Cell Metabol., 23, 591, 10.1016/j.cmet.2016.02.005 Mingrone, 2018, Optimisation of follow-up after metabolic surgery, Lancet Diabetes Endocrinol., 6, 487, 10.1016/S2213-8587(17)30434-5 Nora, 2014, Excess body mass index loss predicts metabolic syndrome remission after gastric bypass, Diabetol. Metab. Syndrome, 6, 1, 10.1186/1758-5996-6-1 2016 Osland, 2016, Postoperative early major and minor complications in laparoscopic vertical sleeve gastrectomy (lvsg) versus laparoscopic roux-en-Y gastric bypass (lrygb) procedures: a meta-analysis and systematic review, Obes. Surg., 26, 2273, 10.1007/s11695-016-2101-8 Otto, 2016, Sleeve gastrectomy and roux-en-Y gastric bypass lead to comparable changes in body composition after adjustment for initial body mass index, Obes. Surg., 26, 479, 10.1007/s11695-015-1792-6 Peterli, 2018, Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial, JAMA, 319, 255, 10.1001/jama.2017.20897 Popkin, 2018, Obesity and the food system transformation in Latin America, Obes Rev Off J Int Assoc Study Obes, 19, 1028, 10.1111/obr.12694 Rasera, 2017, Effectiveness and safety of bariatric surgery in the public healthcare system in Brazil: real-world evidence from a high-volume obesity surgery center, Obes. Surg., 27, 536, 10.1007/s11695-016-2439-y Rossi, 2009, Percentage of excess BMI lost correlates better with improvement of metabolic syndrome after Roux-en-Y gastric bypass in morbidly obese subjects: anthropometric indexes and gastric bypass, Surg. Obes. Relat. Dis., 5, 11, 10.1016/j.soard.2008.08.002 Santos, 2020, Cardiometabolic risk factors and Framingham Risk Score in severely obese patients: baseline data from DieTBra trial, Nutr. Metabol. Cardiovasc. Dis., 30, 474, 10.1016/j.numecd.2019.10.010 Schauer, 2016, Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes, Diabetes Care, 39, 902, 10.2337/dc16-0382 Schroeder, 2016, Treatment of adult obesity with bariatric surgery, Am. Fam. Physician, 93, 31 Sczepaniak, 2015, Comparability of weight loss reporting after gastric bypass and sleeve gastrectomy using BOLD data 2008-2011, Obes. Surg., 25, 788, 10.1007/s11695-014-1496-3 Serdar, 2021, Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies, Biochem. Med., 31, 10.11613/BM.2021.010502 Sinclair, 2018, Metabolic effects of bariatric surgery, Clin. Chem., 64, 72, 10.1373/clinchem.2017.272336 2019 Uranga, 2019, The complex interactions between obesity, metabolism and the brain, Front. Neurosci., 13, 513, 10.3389/fnins.2019.00513 Walle, 2017, Alterations in fatty acid metabolism in response to obesity surgery combined with dietary counseling, Nutr. Diabetes, 7, 10.1038/nutd.2017.33 Wolfe, 2016, Treatment of obesity: weight loss and bariatric surgery, Circ. Res., 118, 1844, 10.1161/CIRCRESAHA.116.307591 World Health Organization, 2020 Ye, 2022, Fat cell size: measurement methods, pathophysiological origins, and relationships with metabolic dysregulations, Endocr. Rev., 43, 35, 10.1210/endrev/bnab018